Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
934 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
3 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
4 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
5 Recruiting In Vivo Dosimetry During Prostate Cancer Radiotherapy
Condition: Prostate Disease
Intervention: Device: Plastic Scintillation Detectors
6 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
7 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
8 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
9 Recruiting Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: tumor marker detection in lymph nodes
10 Recruiting Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer
Condition: Prostate Adenocarcinoma
Intervention: Drug: 18-F-MISO
11 Not yet recruiting Comparison of Two Insertion Technique of I-gel
Conditions: Prostate Cancer;   Prostate Tumor;   Bladder Cancer;   Bladder Tumor
Intervention: Procedure: Rotational technique
12 Recruiting Systemic Treatment of Resistant Metastatic Disease
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21
13 Recruiting Cabozantinib in Treating Men With Castration-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Castration-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis
14 Recruiting Molecular Mechanisms Underlying Prostate Cancer Disparities
Condition: Prostate Cancer
Intervention: Device: Biopsy or prostatectomy
15 Recruiting Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
Condition: Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: Enzalutamide;   Drug: LHRHa
16 Recruiting Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Bone Metastases;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Soft Tissue Metastases;   Stage IV Prostate Cancer
Interventions: Biological: sipuleucel-T;   Radiation: external beam radiation therapy;   Other: laboratory biomarker analysis
17 Unknown  Study of Treatment Choice in Patients With Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: informational intervention;   Other: questionnaire administration
18 Unknown  Active Surveillance for Prostate Cancer With Indolent Features
Condition: Prostate Cancer
Intervention:
19 Recruiting Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Enzalutamide
Conditions: Hormone-Resistant Prostate Cancer;   Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
20 Unknown  Safety Evaluation of ExAblate MRgFUS for Prostate Cancer
Condition: Prostate Cancer
Intervention: Device: ExAblate MRgFUS for prostate cancer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years